Search Results 711-720 of 12414 for ketamine

  1. Tesevatinib in Subjects With ADPKD - Mayo Clinic

    The goal of the study is to compare and evaluate safety and efficacy of tesevatinib 50mg versus placebo in patients with ADPKD. Participation eligibility.

  2. Study to Examine Base Rates, Types, and Severity of Sleep Apnea and Oxygenation Status in Patients Admitted to the Pain Rehabilitation Center (PRC) on Opioid Medication - Mayo Clinic

    Study to Examine Base Rates, Types, and Severity of Sleep Apnea and Oxygenation Status in Patients Admitted to the Pain Rehabilitation Center (PRC) on Opioid ...

  3. A Non-interventional Cohort Safety Study of Patients With hATTR-PN - Mayo Clinic

    About this study. The purpose of this study with the Health Authorities from the United States (US), Canada and Europe, is to collect long-term safety ...

  4. Mayo Clinic

    Lou Myers says despite two knee replacement surgeries, Mayo Clinic surgeons and researchers in Florida got him back to the game he loves quicker thanks to ...

  5. June Tome, M.D. - Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery - Mayo Clinic Research

    June Tome, M.D., is a scholar in the Mayo Clinic Kern Center for the Science of Health Care Delivery.

  6. Kyle W. Klarich, M.D. - Mayo Clinic Faculty Profiles

    Klarich, M.D., has an interest in structural heart disease, cardiomyopathies, tumors (neoplasms) of the heart and valvular heart disease. Focus areas. Papillary ...

  7. Prescription weight-loss drugs: Can they help you? - Mayo Clinic

    Double your impact! ... Your GivingTuesday gift can go 2X as far. Give Now.

  8. Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy - Mayo Clinic

    Antiemetic drugs, such as palonosetron hydrochloride, ondansetron, and granisetron hydrochloride, may help lessen or prevent nausea and vomiting in patients ...

  9. Neoadjuvant Combination Targeted and Immunotherapy for Patients With High-Risk Stage III Melanoma - Mayo Clinic

    Vemurafenib and cobimetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as ...

  10. A Study to Better Understand if Diet and Metabolism are Connected with MS Relapses and Disease Progress in Patients with Pediatric-onset MS - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...